Tight-binding study of interface states in semiconductor heterojunctions

Localized interface states in abrupt semiconductor heterojunctions are studied within a tight-binding model. The intention is to provide a microscopic foundation for the results of similar studies which were based upon the two-band model within the envelope function approximation. In a two-dimensional description, the tight-binding Hamiltonian is constructed such that the Dirac-like bulk spectrum of the two-band model is recovered in the continuum limit. Localized states in heterojunctions are shown to occur under conditions equivalent to those of the two-band model. In particular, shallow interface states are identified in non-inverted junctions with intersecting bulk dispersion curves. As a specific example, the GaSb-AlSb heterojunction is considered. The matching conditions of the envelope function approximation are analyzed within the tight-binding description.Comment: RevTeX, 11 pages, 3 figures, to appear in Phys. Rev.

Solid-state power controllers

Application of solid state power controllers in space shuttle power distribution and control syste

A method of enciphering quantum states

In this paper, we propose a method of enciphering quantum states of two-state systems (qubits) for sending them in secrecy without entangled qubits shared by two legitimate users (Alice and Bob). This method has the following two properties. First, even if an eavesdropper (Eve) steals qubits, she can extract information from them with certain probability at most. Second, Alice and Bob can confirm that the qubits are transmitted between them correctly by measuring a signature. If Eve measures m qubits one by one from n enciphered qubits and sends alternative ones (the Intercept/Resend attack), a probability that Alice and Bob do not notice Eve's action is equal to (3/4)^m or less. Passwords for decryption and the signature are given by classical binary strings and they are disclosed through a public channel. Enciphering classical information by this method is equivalent to the one-time pad method with distributing a classical key (random binary string) by the BB84 protocol. If Eve takes away qubits, Alice and Bob lose the original quantum information. If we apply our method to a state in iteration, Eve's success probability decreases exponentially. We cannot examine security against the case that Eve makes an attack with using entanglement. This remains to be solved in the future.Comment: 21 pages, Latex2e, 10 epsf figures. v2: 22 pages, added two references, several clarifying sentences are added in Sec. 5, typos corrected, a new proof is provided in Appendix A and it is shorter than the old one. v3: 23 pages, one section is adde

Novel amidines and analogues as promising agents against intracellular parasites: a systematic review

Parasitic protozoa comprise diverse aetiological agents responsible for important diseases in humans and animals including sleeping sickness, Chagas disease, leishmaniasis, malaria, toxoplasmosis and others. They are major causes of mortality and morbidity in tropical and subtropical countries, and are also responsible for important economic losses. However, up to now, for most of these parasitic diseases, effective vaccines are lacking and the approved chemotherapeutic compounds present high toxicity, increasing resistance, limited efficacy and require long periods of treatment. Many of these parasitic illnesses predominantly affect low-income populations of developing countries for which new pharmaceutical alternatives are urgently needed. Thus, very low research funding is available. Amidine-containing compounds such as pentamidine are DNA minor groove binders with a broad spectrum of activities against human and veterinary pathogens. Due to their promising microbicidal activity but their rather poor bioavailability and high toxicity, many analogues and derivatives, including pro-drugs, have been synthesized and screened in vitro and in vivo in order to improve their selectivity and pharmacological properties. This review summarizes the knowledge on amidines and analogues with respect to their synthesis, pharmacological profile, mechanistic and biological effects upon a range of intracellular protozoan parasites. The bulk of these data may contribute to the future design and structure optimization of new aromatic dicationic compounds as novel antiparasitic drug candidate

Investigation of the effect of structure modification of furamidine on the DNA minor groove binding and antiprotozoal activity

New analogs of the antiprotozoal agent Furamidine were prepared utilizing Stille coupling reactions and amidation of the bisnitrile intermediate using lithium bis-trimethylsilylamide. Both the phenyl groups and the furan moiety of furamidine were replaced by heterocycles including thiophene, selenophene, indole or benzimidazole. Based upon the DeltaTm and the CD results, the new compounds showed strong binding to the DNA minor groove. The new analogues are also more active both in vitro and in vivo than furamidine. Compounds 7a, 7b, and 7f showed the highest activity in vivo by curing 75% of animals, and this merits further evaluation

The Importance of Racial Socialization: Schoolâ Based Racial Discrimination and Racial Identity Among African American Adolescent Boys and Girls

Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/149540/1/jora12383_am.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/149540/2/jora12383.pd

Pharmacology of DB844, an orally active aza analogue of pafuramidine, in a monkey model of second stage human African trypanosomiasis

Novel drugs to treat human African trypanosomiasis (HAT) are still urgently needed despite the recent addition of nifurtimox-eflornithine combination therapy (NECT) to WHO Model Lists of Essential Medicines against second stage HAT, where parasites have invaded the central nervous system (CNS). The pharmacology of a potential orally available lead compound, N-methoxy-6-{5-[4-(N-methoxyamidino) phenyl]-furan-2-yl}-nicotinamidine (DB844), was evaluated in a vervet monkey model of second stage HAT, following promising results in mice. DB844 was administered orally to vervet monkeys, beginning 28 days post infection (DPI) with Trypanosoma brucei rhodesiense KETRI 2537. DB844 was absorbed and converted to the active metabolite 6-[5-(4-phenylamidinophenyl)-furanyl-2-yl]-nicotinamide (DB820), exhibiting plasma C(max) values of 430 and 190 nM for DB844 and DB820, respectively, after the 14th dose at 6 mg/kg qd. A 100-fold reduction in blood trypanosome counts was observed within 24 h of the third dose and, at the end of treatment evaluation performed four days post the last drug dose, trypanosomes were not detected in the blood or cerebrospinal fluid of any monkey. However, some animals relapsed during the 300 days of post treatment monitoring, resulting in a cure rate of 3/8 (37.5%) and 3/7 (42.9%) for the 5 mg/kg×10 days and the 6 mg/kg×14 days dose regimens respectively. These DB844 efficacy data were an improvement compared with pentamidine and pafuramidine both of which were previously shown to be non-curative in this model of CNS stage HAT. These data show that synthesis of novel diamidines with improved activity against CNS-stage HAT was possible

Encoding a qubit in an oscillator

Quantum error-correcting codes are constructed that embed a finite-dimensional code space in the infinite-dimensional Hilbert space of a system described by continuous quantum variables. These codes exploit the noncommutative geometry of phase space to protect against errors that shift the values of the canonical variables q and p. In the setting of quantum optics, fault-tolerant universal quantum computation can be executed on the protected code subspace using linear optical operations, squeezing, homodyne detection, and photon counting; however, nonlinear mode coupling is required for the preparation of the encoded states. Finite-dimensional versions of these codes can be constructed that protect encoded quantum information against shifts in the amplitude or phase of a d-state system. Continuous-variable codes can be invoked to establish lower bounds on the quantum capacity of Gaussian quantum channels.Comment: 22 pages, 8 figures, REVTeX, title change (qudit -> qubit) requested by Phys. Rev. A, minor correction

Human African trypanosomiasis: pharmacological re-engagement with a neglected disease

This review discusses the challenges of chemotherapy for human African trypanosomiasis (HAT). The few drugs registered for use against the disease are unsatisfactory for a number of reasons. HAT has two stages. In stage 1 the parasites proliferate in the haemolymphatic system. In stage 2 they invade the central nervous system and brain provoking progressive neurological dysfunction leading to symptoms that include the disrupted sleep wake patterns that give HAT its more common name of sleeping sickness. Targeting drugs to the central nervous system offers many challenges. However, it is the cost of drug development for diseases like HAT, that afflict exclusively people of the world's poorest populations, that has been the principal barrier to new drug development and has led to them becoming neglected. Here we review drugs currently registered for HAT, and also discuss the few compounds progressing through clinical trials. Finally we report on new initiatives that might allow progress to be made in developing new and satisfactory drugs for this terrible disease